Assignee profile:

Pulmatrix, Inc.

City:

Lexington, Massachusetts

Country:

United States

Published Applications:

19

Last publication date:

2015-09-10

Patent Grants:

9

Last grant date:

2016-01-12

Top Inventors for applications by Pulmatrix, Inc.

These are the the leading inventors for applications assigned to Pulmatrix, Inc.:

Recent patent applications by Pulmatrix, Inc.

Pulmatrix, Inc. based in Lexington, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-09-10 ✅ Patent 9,233,158 granted on 2016-01-12
US20150250875A1
Human necessities

Dry powder formulations and methods for treating pulmonary diseases

#2 | 2015-08-20
US20150231066A1
Human necessities

MONOVALENT METAL CATION DRY POWDERS FOR INHALATION

#3 | 2015-03-19
US20150079173A1
Human necessities

FORMULATIONS DECREASING PARTICLE EXHALATION

#4 | 2015-01-01 ✅ Patent 8,992,983 granted on 2015-03-31
US20150004233A1
Human necessities

Respirably dry powder comprising calcium lactate, sodium chloride and leucine

#5 | 2014-05-15
US20140134251A1
Human necessities

PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS

#6 | 2013-10-24
US20130281361A1
Human necessities

METHODS OF TREATING AND PREVENTING RHINOVIRUS INFECTION

#7 | 2013-10-10 ✅ Patent 9,642,798 granted on 2017-05-09
US20130266653A1
Human necessities

Monovalent metal cation dry powders for inhalation

#8 | 2013-09-19 ✅ Patent 9,433,576 granted on 2016-09-06
US20130243828A1
Human necessities

Cationic dry powders

#9 | 2013-08-22 ✅ Patent 9,061,352 granted on 2015-06-23
US20130213398A1
Human necessities

Dry powder formulations and methods for treating pulmonary diseases

#10 | 2013-08-08
US20130203715A1
Human necessities

USE OF TRP CHANNEL AGONISTS TO TREAT INFECTIONS

#11 | 2013-06-27
US20130164338A1
Human necessities

TREATMENT OF CYSTIC FIBROSIS USING CALCIUM LACTATE, LEUCINE AND SODIUM CHLORIDE IN A RESPIRAPLE DRY POWDER

#12 | 2013-06-13 ✅ Patent 8,758,824 granted on 2014-06-24
US20130149345A1
Human necessities

Respirably dry powder comprising calcium lactate, sodium chloride and leucine

#13 | 2013-03-28 ✅ Patent 8,591,866 granted on 2013-11-26
US20130078282A1
Human necessities

Formulations decreasing particle exhalation

#14 | 2012-05-03
US20120107414A1
Human necessities

PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS

#15 | 2012-03-22
US20120070417A1
Human necessities

ANTI-INFLUENZA FORMULATIONS AND METHODS

#16 | 2012-03-15
US20120064126A1
Human necessities

DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES

#17 | 2012-03-08
US20120058198A1
Human necessities

METHODS FOR TREATING AND PREVENTING PNEUMONIA AND VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS

#18 | 2008-02-14 ✅ Patent 8,627,821 granted on 2014-01-14
US20080038207A1
Human necessities

Method and device for decreasing contamination

#19 | 2007-11-22 ✅ Patent 8,187,637 granted on 2012-05-29
US20070270502A1
Human necessities

Formulations decreasing particle exhalation

Also check out Pulmatrix, Inc.'s (Lexington, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

15917 ⎘